View More Recent Stories

Mar 30, 2025 11:10PM ROSEN, LEADING INVESTOR COUNSEL, Encourages Zenas BioPharma, Inc. Investors to Inquire About Securities Class Action Investigation - ZBIO

Mar 27, 2025 10:23AM ROSEN, A LONGSTANDING LAW FIRM, Encourages Zenas BioPharma, Inc. Investors to Inquire About Securities Class Action Investigation - ZBIO

Mar 17, 2025 07:05AM Zenas BioPharma (ZBIO) Appoints Lisa von Moltke as Chief Medical Officer

Dec 16, 2024 06:43AM H.C. Wainwright Starts Zenas Biopharma (ZBIO) at Buy

Dec 12, 2024 06:33AM Guggenheim Reiterates Buy Rating on Zenas Biopharma (ZBIO)

Nov 12, 2024 05:32PM Zenas BioPharma, Inc. (ZBIO) Reports Q3 Loss of $5.02

Oct 8, 2024 04:01AM Citi Starts Zenas Biopharma (ZBIO) at Buy

Oct 8, 2024 03:41AM Morgan Stanley Starts Zenas Biopharma (ZBIO) at Overweight

Oct 8, 2024 02:54AM Guggenheim Starts Zenas Biopharma (ZBIO) at Buy

Oct 8, 2024 02:49AM Jefferies Starts Zenas Biopharma (ZBIO) at Buy

Sep 13, 2024 06:18AM Zenas BioPharma (ZBIO) Prices Upsized 13.24M Share IPO at $17/sh

Sep 6, 2024 06:18AM Zenas BioPharma (ZBIO) Files for 11.76M Share IPO at $16-$18/sh

View More Recent Stories